Press Releases
Senator Lee Leads Letter to Defund Federal Vaccine Mandates
Mar 4, 2022
Sen. Mike Lee (R-UT) today led a group of Senators in defense of Americans targeted by President Biden’s vaccine mandates, making clear in a letter to colleagues they will not consent to expedited passage of a funding bill that allows the vaccine mandates to continue. At minimum, the Senators demanded a roll call vote on an amendment to defund the enforcement of remaining federal vaccine mandates on government contractors, members of the military, all other federal employees, and medical care providers.
Sen. Lee Introduces Bill Countering Inflation
Mar 3, 2022
Sen. Mike Lee (R-UT) introduced the Preventing Runaway Inflation in Consumer Expenditures (PRICE) Act today. This bill builds upon Senator Lee’s budget amendment that received 49 votes during the August 2021 budget reconciliation process. The PRICE Act requires a 3/5 majority of Senators to approve new spending measures when the nation’s inflation rate is at or above 3%. Runaway federal spending has been a major contributor to current inflation, which is now charted as the highest rate in four decades
Sen. Lee Introduces Bill Granting Immediate SSDI Benefits for Terminally Ill
Mar 2, 2022
Sen. Mike Lee (R-UT) introduced his Immediate Access for the Terminally Ill Act today. The bill would allow terminally ill patients with certain diagnoses with limited life expectancies to choose to forego the current five-month waiting period and receive Social Security Disability Insurance (SSDI) benefits immediately.
Senator Lee Introduces 1031 Exchange Improvement Act
Feb 18, 2022
Sen. Mike Lee (R-UT) introduced the 1031 Exchange Improvement Act which would eliminate the current 45-day requirement to identify 1031 exchange properties. 1031 exchanges allow taxpayers to roll earnings from real estate sales into near-term future investment properties while deferring the capital gain tax burden until the eventual sale of the ultimate property. The Internal Revenue Service had extended the 45-day period to 120 days during the COVID-19 pandemic.